Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, an online laboratory surveillance system was established to monitor severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time reverse transcription-PCR (rRT-PCR) testing capacities and results. SARS-CoV-2 rRT-PCR testing data were collected from 97 clinical laboratories, including 84 medical institutions and 13 independent clinical laboratories in Korea. We assessed the testing capacities to utilize SARS-CoV-2 rRT-PCR based on surveillance data obtained from February 7th to June 4th, 2020 and evaluated positive result characteristics according to the reagents used and sample types. A total of 1,890,319 SARS-CoV-2 rRT-PCR testing were performed, 2.3% of which were positive. Strong correlations were observed between the envelope (E) gene and RNA-dependent RNA polymerase (RdRp)/nucleocapsid (N) genes threshold cycle (Ct) values for each reagent. No statistically significant differences in gene Ct values were observed between the paired upper and lower respiratory tract samples, except in the N gene for nasopharyngeal swab and sputum samples. Our study showed that clinical laboratories in Korea have rapidly expanded their testing capacities in response to the COVID-19 outbreak, with a peak daily capacity of 34,193 tests. Rapid expansion in testing capacity is a critical component of the national response to the ongoing pandemic
Abstract
In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, an online laboratory surveillance system was established to monitor severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time reverse transcription-PCR (rRT-PCR) testing capacities and results. SARS-CoV-2 rRT-PCR testing data were collected from 97 clinical laboratories, including 84 medical institutions and 13 independent clinical laboratories in Korea. We assessed the testing capacities to utilize SARS-CoV-2 rRT-PCR based on surveillance data obtained from February 7th to June 4th, 2020 and evaluated positive result characteristics according to the reagents used and sample types. A total of 1,890,319 SARS-CoV-2 rRT-PCR testing were performed, 2.3% of which were positive. Strong correlations were observed between the envelope (E) gene and RNA-dependent RNA polymerase (RdRp)/nucleocapsid (N) genes threshold cycle (Ct) values for each reagent. No statistically significant differences in gene Ct values were observed between the paired upper and lower respiratory tract samples, except in the N gene for nasopharyngeal swab and sputum samples. Our study showed that clinical laboratories in Korea have rapidly expanded their testing capacities in response to the COVID-19 outbreak, with a peak daily capacity of 34,193 tests. Rapid expansion in testing capacity is a critical component of the national response to the ongoing pandemic
참고문헌 (15)
- "Coronavirus disease (COVID-19) pandemic"[URL]
- Cheng MP, "Diagnostic testing for severe acute respiratory syndrome-related coronavirus 2: a narrative review", Ann Intern Med, 172, pp.726~734 (2020)
- Rothe C, "Transmission of 2019-nCoV infection from an asymptomatic contact in Germany", N Engl J Med, 382, pp.970~971 (2020)
- Tang YW, "Laboratory diagnosis of COVID-19: current issues and challenges", J Clin Microbiol, 58, pp.e00512~e00520 (2020)
- 김영진, "COVID-19 Testing in South Korea: Current Status and the Need for Faster Diagnostics", Annals of Laboratory Medicine, 40(5), pp.349~350 (2020), 대한진단검사의학회[DOI]
- Sung H, "Preparedness and rapid implementation of external quality assessment helped quickly increase COVID-19 testing capacity in the Republic of Korea", Clin Chem, 66, pp.979~981 (2020)
- Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
- Yeon Joo Lee, "Quality of Ribonucleic Acid Extraction for Real-Time Reverse Transcription-PCR (rRT-PCR) of SARS-CoV-2: Importance of Internal Control Monitoring", Annals of Laboratory Medicine, 40(6), pp.490~492 (2020), 대한진단검사의학회[DOI]
- Heungsup Sung, "COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays", Annals of Laboratory Medicine, 40(6), pp.439~447 (2020), 대한진단검사의학회[DOI]
- 이미경, "Survey of Clinical Laboratory Practices for 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea", Annals of Laboratory Medicine, 36(2), pp.154~161 (2016), 대한진단검사의학회
- Zhao H, "A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012", Euro Surveill, 19, pp.20680~ (2014)
- Wang W, "Detection of SARSCoV-2 in different types of clinical specimens", JAMA, 323, pp.1843~1844 (2020)
- Pan Y, "Viral load of SARS-CoV-2in clinical samples", Lancet Infect Dis, 20, pp.411~412 (2020)
- Lin C, "Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52cases of novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19)", Clin Chem Lab Med, 58, pp.1089~1094 (2020)
- Mohammadi A, "SARS-CoV-2 detection in different respiratory sites: a systematic review and meta-analysis", EBioMedicine, 59, pp.102903~ (2020)